Unknown

Dataset Information

0

Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.


ABSTRACT: Background:Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumor with a high tumor recurrence rate and poor postoperative survival. Recent studies suggest that CD276- (B7-H3) targeted therapy represents a promising therapeutic option for solid tumors. However, little is known about the expression status of CD276 or its association with progression and prognosis of ACC. Methods:Clinical data were retrospectively analyzed from patients who underwent resection of ACC at our institution (n = 48). Archived, formalin-fixed, and paraffin-embedded samples were collected for immunohistochemical analysis, and the correlation between CD276 expression and clinicopathological parameters was evaluated. Kaplan-Meier and univariate/multivariate Cox regression methods were implemented to identify any prognostic effects. Data from The Cancer Genome Atlas (TCGA) ACC cohort (n = 48). Archived, formalin-fixed, and paraffin-embedded samples were collected for immunohistochemical analysis, and the correlation between CD276 expression and clinicopathological parameters was evaluated. Kaplan-Meier and univariate/multivariate Cox regression methods were implemented to identify any prognostic effects. Data from The Cancer Genome Atlas (TCGA) ACC cohort (. Results:Positive expression of CD276 was detected on the cell membrane and in the cytoplasm of cancer cells or tumor-associated vascular cells in 91.67% (44/48) of ACCs. Vascular expression of CD276 was associated with local aggression (higher T stage, P = 0.029) and advanced ENSAT stage (P = 0.029) and advanced ENSAT stage (P = 0.029) and advanced ENSAT stage (P = 0.029) and advanced ENSAT stage (P = 0.029) and advanced ENSAT stage (P = 0.029) and advanced ENSAT stage (. Conclusion:These findings highlight the immune checkpoint factor CD276 as an independent prognostic factor and a potential therapeutic target in ACC.

SUBMITTER: Liang J 

PROVIDER: S-EPMC6977319 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.

Liang Jiayu J   Liu Zhihong Z   Pei Tianjiao T   Xiao Yingming Y   Zhou Liang L   Tang Yongquan Y   Zhou Chuan C   Wu Kan K   Zhang Fuxun F   Zhang Fan F   Yin Xiaoxue X   Chen Ni N   Wei Xin X   Lu Yiping Y   Zhu Yuchun Y  

Disease markers 20200111


<h4>Background</h4>Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumor with a high tumor recurrence rate and poor postoperative survival. Recent studies suggest that CD276- (B7-H3) targeted therapy represents a promising therapeutic option for solid tumors. However, little is known about the expression status of CD276 or its association with progression and prognosis of ACC.<h4>Methods</h4>Clinical data were retrospectively analyzed from patients who underwent resection of ACC at  ...[more]

Similar Datasets

| S-EPMC6069252 | biostudies-literature
| S-EPMC8326801 | biostudies-literature
| S-EPMC4947428 | biostudies-literature
| S-EPMC4148536 | biostudies-literature
| S-EPMC8297592 | biostudies-literature
| S-EPMC5458750 | biostudies-literature
| S-EPMC7383594 | biostudies-literature
| S-EPMC6472081 | biostudies-literature
| S-EPMC5532699 | biostudies-other